Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1988 Oct;95(2):485–500. doi: 10.1111/j.1476-5381.1988.tb11669.x

Pharmacological analysis of postjunctional alpha-adrenoceptors mediating contractions to (-)-noradrenaline in the rabbit isolated lateral saphenous vein can be explained by interacting responses to simultaneous activation of alpha 1- and alpha 2-adrenoceptors.

C J Daly 1, J C McGrath 1, V G Wilson 1
PMCID: PMC1854170  PMID: 2906557

Abstract

1. The pharmacological characteristics of the alpha-adrenoceptor population in the rabbit isolated saphenous vein has been examined with (-)-noradrenaline (NA), as principal agonist, and a number of antagonists with selectivity for either alpha 1- or alpha 2-adrenoceptors. 2. The rank order of potency of various agonists is consistent with a population of alpha 2-adrenoceptors; UK-14304 greater than (-)-noradrenaline = (-)-adrenaline greater than B-HT 920 = cirazoline greater than phenylephrine greater than amidephrine, but the rank order of pA2 values for the antagonists against (-)-noradrenaline: BDF-6143 greater than rauwolscine = prazosin greater than CH-38083 = YM-12617 greater than Wy-26703 = phentolamine greater than corynanthine, is indicative of a mixed population of alpha 1- and alpha 2-adrenoceptors or, alternatively, a new subtype with characteristics of both the alpha 1- and alpha 2-subtypes. 3. Further evidence for two discrete populations of alpha-adrenoceptors is provided by, (a) the potent but non-competitive effect of prazosin against (-)-noradrenaline, (b) the presence of a component of the contractions elicited by NA and phenylephrine which is resistant to the selective alpha 2-adrenoceptor antagonists rauwolscine and CH-38083: these responses were inhibited by the selective alpha 1-adrenoceptor antagonists prazosin and YM-12617, but not by the selective alpha 2-adrenoceptor antagonist BDF-6143 and, (c) the relative potency of the yohimbine diastereoisomers rauwolscine and corynanthine against NA, phenylephrine and UK-14304. 4. In spite of the overwhelming evidence for a population of postjunctional alpha 2-adrenoceptors, prazosin was similarly effective against all agonists and failed to discriminate between those with putative selectivity for alpha 1- and alpha 2-adrenoceptors. This suggests an interaction of the effects of agonists at the two alpha-adrenoceptor subtypes. 5. An attempt has been made to reconcile a number of paradoxical observations with regard to the identification of postjunctional alpha 2-adrenoceptors in vitro, and it is suggested that in many of the isolated blood vessels presently available for examination both subtypes reside on the same smooth muscle cell. The pharmacological consequences of multiple subtypes of receptors mediating the same response is considered.

Full text

PDF
485

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Abel P. W., Minneman K. P. Alpha-1 adrenergic receptor binding and contraction of rat caudal artery. J Pharmacol Exp Ther. 1986 Dec;239(3):678–686. [PubMed] [Google Scholar]
  3. Alabaster V. A., Keir R. F., Peters C. J. Comparison of activity of alpha-adrenoceptor agonists and antagonists in dog and rabbit saphenous vein. Naunyn Schmiedebergs Arch Pharmacol. 1985 Jul;330(1):33–36. doi: 10.1007/BF00586706. [DOI] [PubMed] [Google Scholar]
  4. Alabaster V. A., Keir R. F., Peters C. J. Comparison of potency of alpha 2-adrenoceptor antagonists in vitro: evidence for heterogeneity of alpha 2-adrenoceptors. Br J Pharmacol. 1986 Jul;88(3):607–614. doi: 10.1111/j.1476-5381.1986.tb10241.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bylund D. B. Heterogeneity of alpha-2 adrenergic receptors. Pharmacol Biochem Behav. 1985 May;22(5):835–843. doi: 10.1016/0091-3057(85)90536-2. [DOI] [PubMed] [Google Scholar]
  6. Cambridge D. UK-14,304, a potent and selective alpha2-agonist for the characterisation of alpha-adrenoceptor subtypes. Eur J Pharmacol. 1981 Jul 10;72(4):413–415. doi: 10.1016/0014-2999(81)90588-4. [DOI] [PubMed] [Google Scholar]
  7. Carswell H., Nahorski S. R. Beta-adrenoceptor heterogeneity in guinea-pig airways: comparison of functional and receptor labelling studies. Br J Pharmacol. 1983 Aug;79(4):965–971. doi: 10.1111/j.1476-5381.1983.tb10542.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cavero I., Fenard S., Gomeni R., Lefevre F., Roach A. G. Studies on the mechanism of the vasodilator effects of prazosin in dogs and rabbits. Eur J Pharmacol. 1978 Jun 1;49(3):259–270. doi: 10.1016/0014-2999(78)90101-2. [DOI] [PubMed] [Google Scholar]
  9. Daly C. J., McGrath J. C., Wilson V. G. An examination of the postjunctional alpha-adrenoceptor subtypes for (-)-noradrenaline in several isolated blood vessels from the rabbit. Br J Pharmacol. 1988 Oct;95(2):473–484. doi: 10.1111/j.1476-5381.1988.tb11668.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Daly C. J., McGrath J. C., Wilson V. G. Evidence that the population of postjunctional-adrenoceptors mediating contraction of smooth muscle in the rabbit isolated ear vein is predominantly alpha 2. Br J Pharmacol. 1988 Aug;94(4):1085–1090. doi: 10.1111/j.1476-5381.1988.tb11626.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Docherty J. R., Göthert M., Dieckhöfer C., Starke K. Effects of 4-chloro-2-(2-imidazolin-2-ylamino)-isoindoline Hydrochloride (BE 6143) at pre- and postsynaptic alpha-adrenoceptors in rabbit aorta and pulmonary artery. Arzneimittelforschung. 1982;32(12):1534–1540. [PubMed] [Google Scholar]
  12. Docherty J. R., Starke K. Postsynaptic alpha-adrenoceptor subtypes in rabbit blood vessels and rat anococcygeus muscle studied in vitro. J Cardiovasc Pharmacol. 1981 Jul-Aug;3(4):854–866. doi: 10.1097/00005344-198107000-00019. [DOI] [PubMed] [Google Scholar]
  13. Drew G. M., Whiting S. B. Evidence for two distinct types of postsynaptic alpha-adrenoceptor in vascular smooth muscle in vivo. Br J Pharmacol. 1979 Oct;67(2):207–215. doi: 10.1111/j.1476-5381.1979.tb08668.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Flavahan N. A., McGrath J. C. Blockage by yohimbine of prazosin-resistant pressor effects of adrenaline in the pithed rat. Br J Pharmacol. 1980 Jul;69(3):355–357. doi: 10.1111/j.1476-5381.1980.tb07021.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Flavahan N. A., Vanhoutte P. M. Effect of cooling on alpha-1 and alpha-2 adrenergic responses in canine saphenous and femoral veins. J Pharmacol Exp Ther. 1986 Jul;238(1):139–147. [PubMed] [Google Scholar]
  16. Gisclard V., Flavahan N. A., Vanhoutte P. M. Alpha adrenergic responses of blood vessels of rabbits after ovariectomy and administration of 17 beta-estradiol. J Pharmacol Exp Ther. 1987 Feb;240(2):466–470. [PubMed] [Google Scholar]
  17. Hieble J. P., DeMarinis R. M., Matthews W. D. Evidence for and against heterogeneity of alpha 1-adrenoceptors. Life Sci. 1986 Apr 14;38(15):1339–1350. doi: 10.1016/0024-3205(86)90466-2. [DOI] [PubMed] [Google Scholar]
  18. Hieble J. P., Sarau H. M., Foley J. J., Demarinis R. M., Pendleton R. G. Comparison of central and peripheral alpha 1-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 1982 Mar;318(4):267–273. doi: 10.1007/BF00501164. [DOI] [PubMed] [Google Scholar]
  19. Hieble J. P., Woodward D. F. Different characteristics of postjunctional alpha-adrenoceptors on arterial and venous smooth muscle. Naunyn Schmiedebergs Arch Pharmacol. 1984 Nov;328(1):44–50. doi: 10.1007/BF00496105. [DOI] [PubMed] [Google Scholar]
  20. Honda K., Takenaka T., Miyata-Osawa A., Terai M., Shiono K. Studies on YM-12617: a selective and potent antagonist of postsynaptic alpha 1-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 1985 Jan;328(3):264–272. doi: 10.1007/BF00515552. [DOI] [PubMed] [Google Scholar]
  21. Hooker C. S., Calkins P. J., Fleisch J. H. On the measurement of vascular and respiratory smooth muscle responses in vitro. Blood Vessels. 1977;14(1):1–11. doi: 10.1159/000158110. [DOI] [PubMed] [Google Scholar]
  22. Kapocsi J., Somogyi G. T., Ludvig N., Serfozo P., Harsing L. G., Jr, Woods R. J., Vizi E. S. Neurochemical evidence for two types of presynaptic alpha 2-adrenoceptors. Neurochem Res. 1987 Feb;12(2):141–147. doi: 10.1007/BF00979530. [DOI] [PubMed] [Google Scholar]
  23. Lattimer N., McAdams R. P., Rhodes K. F., Sharma S., Turner S. J., Waterfall J. F. Alpha 2-adrenoceptor antagonism and other pharmacological antagonist properties of some substituted benzoquinolizines and yohimbine in vitro. Naunyn Schmiedebergs Arch Pharmacol. 1984 Oct;327(4):312–318. doi: 10.1007/BF00506242. [DOI] [PubMed] [Google Scholar]
  24. Lattimer N., Rhodes K. F. A difference in the affinity of some selective alpha 2-adrenoceptor antagonists when compared on isolated vasa deferentia of rat and rabbit. Naunyn Schmiedebergs Arch Pharmacol. 1985 May;329(3):278–281. doi: 10.1007/BF00501880. [DOI] [PubMed] [Google Scholar]
  25. Marwood J. F., Chapman K. L., Stokes G. S. Studies that question the existence of alpha-2 adrenoceptors in tail arteries of normotensive Sprague-Dawley rats. J Pharmacol Exp Ther. 1986 Jul;238(1):267–272. [PubMed] [Google Scholar]
  26. McGrath J. C. Alpha-adrenoceptor antagonism by apoyohimbine and some observations on the pharmacology of alpha-adrenoceptors in the rat anococcygeus and vas deferens. Br J Pharmacol. 1984 Aug;82(4):769–781. doi: 10.1111/j.1476-5381.1984.tb16473.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. McGrath J. C. Evidence for more than one type of post-junctional alpha-adrenoceptor. Biochem Pharmacol. 1982 Feb 15;31(4):467–484. doi: 10.1016/0006-2952(82)90147-2. [DOI] [PubMed] [Google Scholar]
  28. Medgett I. C., Langer S. Z. Heterogeneity of smooth muscle alpha adrenoceptors in rat tail artery in vitro. J Pharmacol Exp Ther. 1984 Jun;229(3):823–830. [PubMed] [Google Scholar]
  29. Milnor W. R. Limitations of Schild plots in a two-receptor system: alpha adrenoceptors of vascular smooth muscle. J Pharmacol Exp Ther. 1986 Jul;238(1):237–241. [PubMed] [Google Scholar]
  30. Neylon C. B., Summers R. J. [3H]-rauwolscine binding to alpha 2-adrenoceptors in the mammalian kidney: apparent receptor heterogeneity between species. Br J Pharmacol. 1985 Jun;85(2):349–359. doi: 10.1111/j.1476-5381.1985.tb08868.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Purdy R. E., Krueger C. G., Young S. Evidence for nonclassical alpha adrenoceptor blockade by prazosin in isolated rabbit blood vessels. Life Sci. 1980 Dec 8;27(23):2187–2195. doi: 10.1016/0024-3205(80)90383-5. [DOI] [PubMed] [Google Scholar]
  32. Rajanayagam M. A., Medgett I. C. Greater activation of smooth muscle alpha-2 adrenoceptors by epinephrine in distal than in proximal segments of rat tail artery. J Pharmacol Exp Ther. 1987 Mar;240(3):989–997. [PubMed] [Google Scholar]
  33. Ruffolo R. R., Jr, Rosing E. L., Waddell J. E. Receptor interactions of imidazolines. I. Affinity and efficacy for alpha adrenergic receptors in rat aorta. J Pharmacol Exp Ther. 1979 Jun;209(3):429–436. [PubMed] [Google Scholar]
  34. Schulz J. C., Westfall D. P. A pharmacological analysis of the alpha-adrenoceptor antagonism by prazosin in arteries and veins. Blood Vessels. 1982;19(2):79–87. doi: 10.1159/000158375. [DOI] [PubMed] [Google Scholar]
  35. Schümann H. J., Lues I. Postjunctional alpha-adrenoceptors in the isolated saphenous vein of the rabbit. Characterization and influence of angiotensin. Naunyn Schmiedebergs Arch Pharmacol. 1983 Aug;323(4):328–334. doi: 10.1007/BF00512471. [DOI] [PubMed] [Google Scholar]
  36. Stupecky G. L., Murray D. L., Purdy R. E. Vasoconstrictor threshold synergism and potentiation in the rabbit isolated thoracic aorta. J Pharmacol Exp Ther. 1986 Sep;238(3):802–808. [PubMed] [Google Scholar]
  37. Su C. M., Swamy V. C., Triggle D. J. Postsynaptic alpha-adrenoceptor characterization and Ca2+ channel antagonist and activator actions in rat tail arteries from normotensive and hypertensive animals. Can J Physiol Pharmacol. 1986 Jul;64(7):909–921. doi: 10.1139/y86-157. [DOI] [PubMed] [Google Scholar]
  38. Tayo F. M. Agonist action of yohimbine on the perfused rabbit central ear artery. Blood Vessels. 1982;19(4):197–202. [PubMed] [Google Scholar]
  39. Vizi E. S., Harsing L. G., Jr, Gaal J., Kapocsi J., Bernath S., Somogyi G. T. CH-38083, a selective, potent antagonist of alpha-2 adrenoceptors. J Pharmacol Exp Ther. 1986 Aug;238(2):701–706. [PubMed] [Google Scholar]
  40. Weiss R. J., Webb R. C., Smith C. B. Alpha-2 adrenoreceptors on arterial smooth muscle: selective labeling by [3H]clonidine. J Pharmacol Exp Ther. 1983 Jun;225(3):599–605. [PubMed] [Google Scholar]
  41. Weitzell R., Tanaka T., Starke K. Pre- and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit. Naunyn Schmiedebergs Arch Pharmacol. 1979 Aug;308(2):127–136. doi: 10.1007/BF00499054. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES